EVALUATION BY PRACTICING DOCTORS OF THE MODERN PHARMACOTHERAPY POSSIBILITIES IN PATIENTS WITH ISCHEMIC HEART DISEASE. RESULTS OF DOCTOR INTERVIEW IN MOSCOW AND VORONEZH
https://doi.org/10.20996/1819-6446-2010-6-2-145-148
Abstract
Aim. To evaluate opinion of doctors about modern pharmacotherapy possibilities in patients with ischemic heart disease (IHD) and about basic problems of pharmacotherapy implementation.
Material and methods. Interviews of doctors from various health care institutions in Moscow and Voronezh were performed in 2009. Interview was performed with questionnaire containing 5 questions. Doctors of different specialties (n=64 from Moscow and n=69 from Voronezh) participated in interviewing.
Results. The majority of doctors in Moscow and Voronezh were sure in advantage of IHD pharmacotherapy vs coronary angioplasty and stenting (55% and 63%, respectively). Only 37% and 32% of doctors in Moscow and Voronezh, respectively, believed in real achievement of target levels of low density cholesterol and 45% and 61% of them, respectively, considered high cost of statins as the main limit for its implementation.
Conclusion. On one hand interviews among practicing doctors in Moscow and Voronezh demonstrated satisfied knowledge of modern clinical guidelines on IHD therapy. On the other hand they gave understanding why doctors not always follow these guidelines.
About the Authors
S. Yu. Martsevich
State Research Center for Preventive Medicine of Rosmedtechnology,
Moscow Medical Academy named after I.M.Setchenov
Russian Federation
Russian Federation
Petroverigsky per. 10, Moscow, 101990
Chair of Evidence Based Medicine
Bolshaya Pirogovskaya ul. 6, Moscow, 119991
L. Yu. Drozdova
State Research Center for Preventive Medicine of Rosmedtechnology
Russian Federation
Petroverigsky per. 10, Moscow, 101990
Russian Federation
Petroverigsky per. 10, Moscow, 101990
Yu. V. Lukina
State Research Center for Preventive Medicine of Rosmedtechnology,
Moscow Medical Academy named after I.M.Setchenov
Russian Federation
Russian Federation
Petroverigsky per. 10, Moscow, 101990
Chair of Evidence Based Medicine
Bolshaya Pirogovskaya ul. 6, Moscow, 119991
N. V. Sinyagina
State Research Center for Preventive Medicine of Rosmedtechnology
Russian Federation
Petroverigsky per. 10, Moscow, 101990
Russian Federation
Petroverigsky per. 10, Moscow, 101990
T. G. Kheliya
State Research Center for Preventive Medicine of Rosmedtechnology
Russian Federation
Petroverigsky per. 10, Moscow, 101990
Russian Federation
Petroverigsky per. 10, Moscow, 101990
References
1. Fraker T.D.Jr., Fihn S.D., Gibbons R.J. et al. American College of Cardiology; American Heart Association; American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group. 2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina. Circulation 2007;116(23):2762-72.
2. Fox K., Garcia M.A., Ardissino D., et al. Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006 27(11):1341-81.
3. Диагностика и лечение стабильной стенокардии. Рекомендации Всероссийского научного общества кардиологов. Кардиоваскулярная терапия и профилактика 2008;7(6 Приложение 4):3-35.
4. Eastaugh J.L., Calvert M.J., Freemantle N. Highlighting the need for better patient care in stable angina: results of the international Angina Treatment Patterns (ATP) Survey in 7074 patients. Fam Pract 2005;22(1):43-50.
5. Оганов Р.Г., Погосова Г.В., Колтунов И.Е., и др. РЕЛИФ — Регулярное Лечение И профилактика — ключ к улучшению ситуации с сердечно-сосудистыми заболеваниями в России: результаты российского многоцентрового исследования. Часть III. Кардиология 2008;48(4):46-53.
6. Шальнова С.А., Деев А.Д. Уроки исследования ОСКАР — "Эпидемиология и особенности терапии пациентов высокого риска в реальной клинической практике 2005-2006 гг." Кардиоваскулярная терапия и профилактика 2007;6(1):47-53.
7. Boden W.E., O'Rourke R.A., Teo K.K. et al. COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356(15):1503-16.
Review
For citations:
Martsevich S.Yu., Drozdova L.Yu., Lukina Yu.V., Sinyagina N.V., Kheliya T.G. EVALUATION BY PRACTICING DOCTORS OF THE MODERN PHARMACOTHERAPY POSSIBILITIES IN PATIENTS WITH ISCHEMIC HEART DISEASE. RESULTS OF DOCTOR INTERVIEW IN MOSCOW AND VORONEZH. Rational Pharmacotherapy in Cardiology. 2010;6(2):145-148. (In Russ.) https://doi.org/10.20996/1819-6446-2010-6-2-145-148
Views:
616
Email this article 